2024 Award Recipients
Barbara T. Murphy Award
Vesna D. Garovic, MD, PhD, FASN
ASN will present the Barbara T. Murphy Award to Vesna D. Garovic, MD, PhD, FASN, on Saturday, October 26. This is just the fourth presentation of this award, which was named after the nephrology leader and late ASN president-elect. It honors leaders who strengthen the foundation of nephrology while advancing the field through innovation, creativity, inspiration, and tenacity.
Dr. Garovic is professor of medicine and chair of the Division of Nephrology and Hypertension at the Mayo Clinic in Rochester, MN. She holds a joint appointment in the Department of Obstetrics and Gynecology and is vice chair for research in the Department of Internal Medicine, director of the Mayo Clinic Center for Clinical and Translational Science, and dean of clinical and translational science at the Mayo Clinic.
When she recognized the unmet need for nephrologists to develop expertise in pregnancy-related kidney and cardiovascular diseases, she became a pioneer who dedicated her career to this field of inquiry. She has been funded by the National Institutes of Health (NIH) for the past 15 years and has published more than 200 peer-reviewed papers.
Dr. Garovic's clinical and research interests in hypertension, in general, and hypertensive pregnancy disorders, in particular, span several research areas: diagnosis, treatment, and underlying molecular mechanisms, with a recent focus on the senescence, epigenetics, and epidemiology of cardiovascular and renal complications.
She served as a chartered member of the NIH Pregnancy and Neonatology Study Section and as a member of the American Heart Association (AHA) Councils on Hypertension and on the Kidney in Cardiovascular Disease Science Subcommittee. She chaired the Writing Group for the AHA scientific statement on hypertension in pregnancy. Among many honors, Dr. Garovic received the Marvin Moser Clinical Hypertension Award from the AHA and the Council on Hypertension.
Dr. Garovic earned her medical degree, a master's of science in biochemistry, and a doctorate in molecular biology and obstetrics and gynecology at the University of Belgrade in Serbia, where she also completed a residency and fellowship in obstetrics and gynecology. She earned a second master's in medical genetics from McGill University in Montreal, Quebec, Canada. She then completed an internal medicine residency and nephrology fellowship at the Albert Einstein College of Medicine and Montefiore Medical Center in New York City.
Robert G. Narins Award
Scott J. Gilbert, MD, FASN
Scott J. Gilbert, MD, FASN, will receive the Robert G. Narins Award on Friday, October 25, for his many efforts in the education and training of the next generation of nephrologists. Dr. Gilbert is professor of medicine at Tufts University School of Medicine and a nephrologist at Tufts Medical Center in Boston, MA. He also directs the nephrology fellowship program and core faculty of the internal medicine residency program.
At Tufts University School of Medicine, he has led the first-year renal course for more than 20 years, coordinates the fourth-year consultative nephrology elective, and leads sessions in courses on problem-based learning, introduction to clinical reasoning, and medical ethics. He is an academic coach for 20 medical students through their 4-year medical school experience.
He is active in premedical mentoring at Tufts University, serving as faculty adviser to the Minority Association of Pre-Health Students, an organization for racial and ethnic minorities who are under-represented in health care, with an interest in the health professions, as well as the Kidney Disease Screening and Awareness Program, a student-run organization that provides blood pressure, blood sugar, and urinalysis screening in underserved communities in the Boston area.
Dr. Gilbert recently engaged in programs to promote diversity in medicine as a program leader and career mentor in the Tufts University School of Medicine/University of Massachusetts Boston Enrichment Program and through the development and oversight of a summer clinical immersion program for undergraduate students who are under-represented and underserved and are “first in family” to attend college, showcasing career opportunities in health care that they might not have known about. He is editor of the National Kidney Foundation's Primer on Kidney Diseases, previously served as education editor for the American Journal of Kidney Diseases, and chaired the ASN Workforce and Training Committee.
He attended Washington University School of Medicine in St. Louis, MO, before completing an internal medicine residency and nephrology fellowship at Beth Israel Deaconess Medical Center.
Belding H. Scribner Award
Claudio Ronco, MD
The Belding H. Scribner Award will be tendered on Saturday, October 26, to Claudio Ronco, MD. Dr. Ronco's clinical and basic research efforts have significantly advanced the management of patients with kidney diseases and the science of nephrology.
Dr. Ronco is director of the International Renal Research Institute at San Bortolo Hospital in Vicenza, Italy, where he also served as director of the Department of Nephrology and Transplantation. He has also held positions as associate professor of nephrology at San Bartolo Hospital, director of the renal laboratory at the International Renal Research Institute, professor of medicine at the Albert Einstein College of Medicine and Beth Israel Deaconess Medical Center in New York City, and visiting professor at The George Washington University in Washington, DC.
Established in 1995, the Belding H. Scribner Award is presented to individuals who have made outstanding contributions to the care of patients with renal disorders or have substantially influenced the clinical practice of nephrology. Dr. Ronco is receiving the award because of his achievements as a pioneer in many areas of nephrology, including peritoneal dialysis, critical care nephrology, continuous renal replacement therapy, cardiorenal syndromes, and wearable dialysis technology. He has coauthored 1146 papers, 65 books, and 80 book chapters and has delivered more than 1000 lectures and presentations at international meetings and universities.
Dr. Ronco has served on the board of directors of five scientific societies and served as president of the International Society for Hemodialysis. He cofounded the Acute Dialysis Quality Initiative consensus group with colleagues from the University of California and the University of Pittsburgh. He is editor-in-chief of Blood Purification and Contributions to Nephrology, associate editor of Critical Care, and editor emeritus of The International Journal of Artificial Organs.
Dr. Ronco has received numerous awards including lifetime achievement awards for hemodialysis and peritoneal dialysis from the Annual Dialysis Conference, the Bywaters Award from the International Society of Nephrology, an international medal of excellence and the J. Michael Lazarus Distinguished Award from the National Kidney Foundation, and the Belding Scribner Award from the International Society for Hemodialysis.
Dr. Ronco graduated in medicine from the University of Padua in Italy and then completed specialty training in nephrology at the University of Padua and in pediatric nephrology at the University of Naples Federico II, Italy.
John P. Peters Award
Susan E. Quaggin, MD, FASN
ASN will recognize the wide-ranging contributions of Susan E. Quaggin, MD, FASN, with the presentation of the John P. Peters Award on Friday, October 25. This award is given for outstanding contributions to improving the lives of patients and furthering the understanding of the kidney in health and disease.
Dr. Quaggin is the Irving S. Cutter Professor of Medicine at Northwestern University Feinberg School of Medicine, where she also chairs the Department of Medicine and directs the Feinberg Cardiovascular and Renal Research Institute.
Her research focuses on the fundamental processes needed to establish and maintain the integrity of the specialized vascular beds in the kidney and eye. To understand and identify new therapeutic targets, she developed genetic mouse models that allow cell- and time-specific manipulation of functional genes. Her group's findings about the vasculature have revealed pathogenic mechanisms and have led to new therapeutic targets for a number of diseases, including diabetic kidney disease, nephrotic syndrome, and glaucoma.
Dr. Quaggin has served ASN in many roles, including as president; associate editor of JASN; chair of Kidney Week's Program Committee and of the Diabetic Kidney Disease Collaborative Task Force; and member of the Public Policy Board, Education Committee, Grants Review Committee, and more. She has also served on the councils of The American Society for Clinical Investigation and the International Society of Nephrology. She chaired the National Institutes of Health's pathobiology of kidney disease study section. She is on the scientific advisory boards of AstraZeneca and Roche and is cofounder of Mannin Research.
Among her many honors, Dr. Quaggin received the International Society of Nephrology Alfred Newton Richards Award for basic research, a Kidney Foundation of Canada medal for research excellence, an American Heart Association distinguished scientist award, and an honorary doctorate from the University of Southern Denmark. She was corecipient of the Grand Prix Scientifique from the Fondation Lefoulon-Delalande.
Dr. Quaggin received her medical degree from the University of Toronto and completed her residency at the university's St. Michael's Hospital. She completed her nephrology fellowship and additional research training at the University of Toronto and Yale University. She also trained in the developmental biology program at the University of Toronto's Samuel Lunenfeld Research Institute.
Homer W. Smith Award
Joseph V. Bonventre, MD, PhD, FASN
Prominent investigator Joseph V. Bonventre, MD, PhD, FASN, will be presented the Homer W. Smith Award on Saturday, October 26. This award recognizes outstanding contributions to understanding how kidneys function in normal and diseased states. Dr. Bonventre will speak on “Acute Kidney Injury, Repair, and Generation of Kidney Tissue.”
He is the Samuel A. Levine Professor of Medicine at Harvard Medical School and professor of health sciences and technology at the Massachusetts Institute of Technology (MIT). He is also chief of the Renal (Kidney) Medicine Division and founding chief of the Engineering in Medicine Division at Brigham and Women's Hospital. He directed the Harvard-MIT Program in Health Sciences and Technology for 10 years.
Dr. Bonventre's research focuses primarily on the study of kidney injury and repair and signal transduction, with an emphasis on the role of inflammation, biomarkers, and stem cells. His recent work also involves the generation of kidney organoids from stem cells and their use in kidney disease modeling. Among many discoveries, Dr. Bonventre established the origin of epithelial cells that repair the kidney after injury as dedifferentiated surviving proximal tubule cells. He was the first to describe the role of proximal tubule cell cycle arrest in maladaptive fibrosis that can occur after severe injury leading to chronic kidney disease.
He has published more than 420 original research papers; 160 reviews, chapters, and editorials; and 3 books. His work has been referenced more than 94,000 times, and he is one of the most frequently cited authors in the area of acute kidney injury.
Dr. Bonventre is past president of ASN, a founding member of the board of directors of the National Space Biomedical Research Institute, and a member of the Executive Committee of the Harvard Stem Cell Institute. He is a past councilor of the International Society of Nephrology. He has chaired many National Institutes of Health (NIH) study sections, served as a member of the Advisory Council of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and is editor of Seminars in Nephrology. Among many honors, he has received the Osler Medal of the Royal College of Physicians, the Bywaters Award of the International Society of Nephrology, the Massry Award of the National Kidney Foundation, two MERIT awards from the NIH-NIDDK, and honorary doctorates from Mount Saint Mary College and the Norwegian University of Science and Technology.
Dr. Bonventre received an MD and a PhD in biophysics from Harvard University. He completed his residency, clinical fellowship, and research fellowship at Massachusetts General Hospital and Harvard University.
Donald W. Seldin Young Investigator Award
Hiddo Jan L. Heerspink, PhD
The ASN-American Heart Association Donald W. Seldin Young Investigator Award will be presented to Hiddo Jan L. Heerspink, PhD, who will speak on “Innovations in Clinical Trial Design and Conduct for New Therapeutic Approaches in CKD” on Friday, October 25.
Dr. Heerspink is professor of clinical trials and personalized medicine and a clinical trialist in the Department of Clinical Pharmacy and Pharmacology at the University Medical Center Groningen in The Netherlands. He is also a visiting professor at the University of New South Wales, Sydney, Australia.
Dr. Heerspink's research focuses on optimizing treatment strategies and finding new therapeutic approaches to halt the progression of chronic kidney disease (CKD) and cardiovascular disease. His main expertise includes clinical trial design, personalized medicine, and methodology and statistical analysis of clinical trials. He has successfully led and currently leads numerous clinical trials, including trials of dapagliflozin in CKD (DAPA-CKD), finerenone in nondiabetic CKD (FIND-CKD), atrasentan in patients with immunoglobulin A nephropathy (ALIGN), and a comparison of drugs in treating CKD and high proteinuria (ZENITH-CKD).
Dr. Heerspink has published more than 500 peer-reviewed publications and is an editorial board member of Diabetes, Obesity and Metabolism and CJASN. He holds five patents in the areas of biomarkers and CKD. He serves as a member of various committees of international professional organizations, including ASN and the American Diabetes Association.
Among many honors, he has received the Foreign Scientist Award from the Japanese Diabetes Society, the Rising Star Award and the Camillo Golgi Prize from the European Association for the Study of Diabetes, a Young Researcher Award from the Canadian Society Nephrology, and a Top Publication Award from the Dutch Society for Clinical Pharmacology & Biopharmacy.
Dr. Heerspink studied pharmacology at the University of Groningen and received his PhD from the University Medical Center Groningen.
President's Medal
Alonzo Mourning
Hall-of-Fame basketball player and kidney transplant recipient Alonzo Mourning will receive an ASN President's Medal during the opening plenary on Thursday, October 24, in recognition of his work in raising awareness about kidney diseases, as well as raising funds for kidney research and social justice programs. ASN presents this medal to individuals who have advanced the association's mission to fight against kidney diseases by educating health professionals, sharing new knowledge, advancing research, and advocating for patients.
Mr. Mourning was enjoying a stellar basketball career—having won a gold medal as part of the US team at the 2000 Summer Olympics in Sydney, Australia—when he noticed extreme swelling in his legs and feet accompanied by uncharacteristic fatigue. He was soon diagnosed with focal segmental glomerulosclerosis (FSGS), and genetic testing revealed that he carries the APOL1 gene variant. He missed the entire 2002–2003 National Basketball Association (NBA) season due to his kidney disease. A relative donated a kidney for a successful transplant in 2003. He not only returned to play the next year, but in 2006, he won an NBA championship as a key player for the Miami Heat.
Mr. Mourning was an active philanthropist prior to his illness. He cofounded the Mourning Family Foundation in 1997 to focus on youth development through advocacy, education, and enrichment. Since then, he has been instrumental in raising more than $50 million for various programs, including building a state-of-the-art youth center aimed at bridging gaps and strengthening communities in the urban core in the South Florida area of Overtown.
After being diagnosed with FSGS, he also turned his attention to raising money and awareness as a kidney health advocate. He began with a campaign using his nickname, establishing Zo's Fund for Life, which raised $2 million for FSGS, providing research into treatment, education, and financial relief for patients who cannot afford medication. He continues to raise awareness about the importance of becoming an organ donor. He works with the National Kidney Foundation to educate the public on the importance of early detection of kidney diseases.
Mr. Mourning has received numerous honors, including the NBA Community Assist Award, the National Urban League Outstanding Community Service Award, the National Conference for Community and Justice Silver Medallion Community Service Award, the NBA J. Walter Kennedy Citizenship Award, the Children's Trust Excellence Award for Public Policy, and the Florida Blue Foundation Sapphire Award. He was inducted into the Naismith Memorial Basketball Hall of Fame in 2014 after a multiyear career with the Charlotte Hornets, Miami Heat, and New Jersey Nets.
Mr. Mourning graduated from Georgetown University with a degree in sociology. He is a member of the President's Council on Sports, Fitness and Nutrition; a member of his alma mater's board of directors; and vice president of player programs and development for the Miami Heat.
Distinguished Educator Award
Laura J. Maursetter, DO, FASN
Dr. Maursetter is associate professor of medicine in the Division of Nephrology at the University of Wisconsin School of Medicine and Public Health and chief of medicine subspecialties at the William S. Middleton Memorial Veterans’ Hospital in Madison.
Her career has focused on educational innovations at both local and national levels. An active member of ASN, she served on the Training Program Directors Committee, in which she helped to develop the initial method for program directors across the country to connect. As a member of the Workforce Committee, she was a leader in getting the Kidney TREKS (Tutored Research and Education for Kidney Scholars) program started and expanded to its present two locations to reach a broader audience. As a member of the Continuing Professional Development Committee, she has helped to lead the Board Review Course and Update over the past 7 years.
At the University of Wisconsin School of Medicine and Public Health, she was a nephrology fellowship program director, in which she created curricula in simulation, asynchronous quality improvement, and mentorship. In addition, she created both just-in-time and longitudinal evaluation systems to more efficiently assess and provide feedback to learners across the system. Dr. Maursetter was also instrumental in creating curricula for the medical school for both the Acute Care block and the Division of Nephrology. Her clinical work focuses on the underserved populations of Veterans Affairs and the Department of Corrections.
She has been honored with excellence in teaching awards from the University of Wisconsin.
Dr. Maursetter received her medical degree from the Chicago College of Osteopathic Medicine before completing her internal medicine residency at Advocate Lutheran General Hospital in Chicago. She completed her nephrology fellowship at the University of Wisconsin before joining the faculty.
Samira S. Farouk, MD, MS, FASN
Dr. Farouk is a transplant nephrologist, associate professor of medicine and medical education, associate program director of the nephrology fellowship program, and social media director of the Division of Nephrology at the Icahn School of Medicine at Mount Sinai in New York City.
Involved in all levels of medical education, Dr. Farouk teaches medical students, residents, and fellows. She is interested in the development and study of innovative medical educational tools and technologies, including free open access medical education and social media. She is a cofounder of the mobile-friendly, teaching-tool website NephSIM, founder of the virtual nephrology mentoring program NephSIM Nephrons, and cofaculty lead of the Renal Fellow Network.
She served on the executive committee of NephMadness and the Nephrology Social Media Collective. She is currently deputy codirector of the ASN Board Review Course and Update, president of The New York Society of Nephrology, associate editor of Kidney Medicine, and a member of the editorial boards of several journals, including the American Journal of Kidney Diseases and Clinical Transplantation. Among many honors, Dr. Farouk has received the ASN William and Sandra Bennett Clinical Scholars Program KidneyCure Award, was the winner of the 2018 ASN Innovations in Kidney Education Contest, and has received many teaching awards.
She received her medical degree from the Rutgers University Robert Wood Johnson Medical School, where she graduated with a distinction in research. She completed her internship, residency, and nephrology and transplant fellowship at the Icahn School of Medicine at Mount Sinai.
Abhilash Koratala, MD, FASN
Dr. Koratala is associate professor of medicine and director of clinical imaging for nephrology at the Medical College of Wisconsin. He is internationally known for his expertise in point-of-care ultrasonography (POCUS), particularly in bedside hemodynamic assessment using Doppler techniques, and for his educational efforts supporting it.
Dr. Koratala has delivered more than 100 invited talks on POCUS globally. He has developed comprehensive POCUS curricula for nephrology trainees, which have been published in the American Journal of Kidney Diseases and Kidney360. Dr. Koratala also teaches POCUS on online platforms such as Twitter/X, in which his handle @NephroP is among the most followed in medical education, boasting over 65,000 followers. He authors posts for “Focus on POCUS” on the Renal Fellow Network, a nephrology blog published in partnership with ASN. He serves as associate editor of the POCUS Journal.
His online POCUS teaching tool won the ASN Innovations in Kidney Education Contest in 2020. He won an educational tools contest sponsored by the American Heart Association Council on the Kidney in Cardiovascular Disease and has received exemplary teacher awards from the University of Florida. In addition to his expertise in POCUS, Dr. Koratala's work in all aspects of nephrology has led to more than 200 publications in peer-reviewed journals.
Dr. Koratala received his medical degree from Kakatiya Medical College in Warangal, India. He completed a residency in internal medicine at the BronxCare Health System (formerly Bronx Lebanon Hospital Center) in New York City, a fellowship in nephrology at the University of Florida in Gainesville, and a mini-fellowship in renal ultrasonography at Emory University in Atlanta.
Distinguished Leader Award
Charuhas V. Thakar, MD, FASN
Dr. Thakar is director of the Wellcome-Wolfson Institute for Experimental Medicine in the School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast, Northern Ireland.
He has more than 2 decades of administrative and leadership experience in complex health care environments, including governmental, nonprofit, academic, and private sectors. He served as the Robert G. Luke Endowed Chair in Nephrology and director of the Division of Nephrology at the University of Cincinnati from 2013 to 2023 and was also chief of the renal section at the Cincinnati VA Medical Center from 2005 to 2024.
Dr. Thakar is internationally recognized for his research related to acute kidney injury and progression of chronic kidney disease. His research has been funded by the US Department of Veterans Affairs, the National Institutes of Health, and other research foundations. His work has been published in top peer-reviewed journals in nephrology and more general medicine.
He currently serves the National Kidney Foundation on its Scientific Advisory Board and as editor-in-chief of Advances in Kidney Disease and Health. He serves on the Scientific Advisory Boards of several other organizations, including the Northern Ireland Kidney Research Fund, Fresenius NxStage critical care, and the Dialysis Clinic, Inc. He served as a member of the ASN Acute Kidney Injury Advisory Group.
Dr. Thakar received his medical degree from Bharati Vidyapeeth Medical College, University of Pune, India. He then completed a residency in internal medicine at Yale University, followed by a clinical and research fellowship in nephrology at the Cleveland Clinic Foundation. He also completed an executive leadership program in managing health care delivery at Harvard Business School.
Amanda Hyre Anderson, PhD, MPH, FASN
Dr. Anderson is professor of epidemiology and medicine at The University of Alabama at Birmingham (UAB); vice chair for research in the Department of Epidemiology at The UAB School of Public Health; codirector of the Biostatistics, Epidemiology and Research Design unit of The UAB Center for Clinical and Translational Science; and adjunct professor of epidemiology at the Perelman School of Medicine at the University of Pennsylvania and at Tulane University.
A renal and cardiovascular disease epidemiologist with over 20 years of experience conducting epidemiological research, with a specialty in chronic kidney disease, Dr. Anderson is an active ASN member, having just completed her fourth year on the Publications Committee.
Her leadership has spanned across research, academics, administration, and service. She has participated in more than 20 National Institutes of Health-funded research projects and training grants. She is a principal investigator (PI) for the Chronic Renal Insufficiency Cohort (CRIC) Study Scientific and Data Coordinating Center. As contact PI for the George M. O’Brien Kidney Resource Alliance National Coordinating Center, she works with seven O’Brien Kidney National Resource Centers in support of kidney disease research nationwide. Dr. Anderson is also contact PI for a National Institutes of Health study investigating the gut microbiome and metabolome among a subset of participants in the CRIC study. She is also engaged in academic and administrative leadership at her university, serving on deans’ councils, research advisory councils, and the faculty council.
She has published in high-impact nephrology journals and leading general medicine journals, including The New England Journal of Medicine, the Journal of the American Medical Association, and Annals of Internal Medicine.
Dr. Anderson received her MPH and PhD, both in epidemiology, from Tulane University.
Distinguished Researcher Award
Vishal Patel, MD
Dr. Patel holds the Yin Quan-Yuen Distinguished Professorship in Nephrology in the Department of Internal Medicine at The University of Texas Southwestern Medical Center in Dallas.
Dr. Patel's research focuses on mRNA translation regulation, RNA chemical modifications, and noncoding RNAs in the context of polycystic kidney disease (PKD) and kidney development. His laboratory provided the first evidence that microRNAs directly inhibit PKD1 (the gene mutated in PKD) and thereby promote PKD pathogenesis. The team devised an endogenous, mutation-agnostic PKD1/2 mRNA therapy for autosomal-dominant PKD. This drug is now in clinical trials, marking a major advance in the field. In addition, his laboratory has identified many other microRNAs that may play a pathogenic role in PKD.
The National Institutes of Health (NIH) has funded Dr. Patel's laboratory continuously since 2009, with the Department of Defense providing additional funding. The research has resulted in several patents and has been published in prestigious journals such as the Proceedings of the National Academy of Sciences USA, Nature Communications, and Cell Metabolism.
Dr. Patel is active in several national leadership positions. He serves as a member and chair of several NIH and Department of Defense grant study sections. He chairs the Scientific Advisory Committee and is a member of the board of directors of the PKD Foundation. He serves as a consultant for many pharmaceutical companies.
Dr. Patel obtained his medical degree from Pramukhswami Medical College in Karamsad, India. He completed his internal medicine residency at Northwestern University and a clinical nephrology fellowship at UT Southwestern. Following his clinical training, he was an NIH-funded physician-scientist trainee at UT Southwestern, studying kidney genetics and primary cilia biology.
Mara McAdams-DeMarco, PhD
Dr. McAdams DeMarco is an epidemiologist and associate professor at the New York University Grossman School of Medicine in New York City. She leads the Epidemiology of Aging in End Stage Kidney Disease laboratory and co-leads the NYU Kidney Disease and Health Community Advisory Board as well as the Kidney Disease and Aging Research Collaborative.
Her research focuses on the intersection of aging and kidney failure with a particular emphasis on older candidates and recipients undergoing kidney transplant. She conducted some of the first studies of frailty, delirium, cognitive function, and Alzheimer disease among older patients undergoing kidney transplant.
Dr. McAdams DeMarco is the principal investigator of the oldest and largest cohort study of frailty among kidney transplant candidates and recipients and of clinical trials of exercise interventions to prevent cognitive aging. Her studies have explored how novel aging metrics (such as frailty, cognitive function, physical function, and quality of life) can help improve risk prediction of adverse outcomes in older recipients of kidney transplant and identify interventions to prevent adverse outcomes of aging. Her overarching career objectives are to improve the care and well-being of older patients with kidney failure. Among many honors, she has received two junior investigator awards from the American Society of Transplant Surgeons.
Dr. McAdams DeMarco received an MS in epidemiology from the Harvard T.H. Chan School of Public Health and a PhD in epidemiology from the Johns Hopkins Bloomberg School of Public Health.
Michael T. Eadon, MD, FASN
Dr. Eadon is associate professor of medicine, associate professor of medical and molecular genetics, and the David M. and Julie B. DeWitt Scholar in Nephrology Research at the Indiana University School of Medicine in Indianapolis. He is a translational physician-scientist with accomplishments in the realms of pharmacogenomic discovery, construction of a molecular atlas of the kidney in health and disease, and implementation of pharmacogenomics and genomics in chronic kidney disease.
Dr. Eadon's research focuses primarily on the implementation of pharmacogenomics into clinical practice as well as the identification of novel predictors of renal injury from large genomic, transcriptomic, and proteomic data sets. A major focus is the evaluation of renal disease expression patterns with spatial transcriptomics and understanding the genetic variants that affect this expression.
He is an active member of the National Institute of Diabetes and Digestive and Kidney Disease's Kidney Precision Medicine Project, integrating diverse orthogonal data sets to characterize molecular patterns of kidney diseases in individuals who have had a kidney biopsy. A second focus of his research is translating genetic determinants of an antihypertensive drug response and the progression of kidney diseases into clinical practice. He is also an active contributor to the National Human Genome Research Institute's Implementing Genomics in Practice Consortium. He also serves on the ASN Publications Committee. Dr. Eadon is a practicing clinician at Eskenazi Health, Indiana University Health, and the Richard L. Roudebush Veterans’ Administration Medical Center.
He received his MD from Rush University, followed by an internal medicine residency at Baylor College of Medicine and a combined research fellowship in nephrology, glomerulonephritis, and clinical pharmacology at The University of Chicago.
Distinguished Clinical Service Award
Neera K. Dahl, MD, PhD, FASN
Dr. Dahl is a senior associate consultant in the Division of Nephrology and Hypertension at the Mayo Clinic Rochester and adjunct professor in the Section of Nephrology at Yale School of Medicine. She directs the Mayo Clinic's Polycystic Kidney Disease Foundation Center of Excellence.
During her time as a clinician-educator at Yale from 2007 to 2023, she ran the Yale Inherited Diseases of the Kidney program, which focused on autosomal-dominant polycystic kidney disease (ADPKD). She built a clinical trials program to support research opportunities for her patients. Dr. Dahl was the principal investigator for every major industry-sponsored clinical trial in ADPKD, including the development of treatment with tolvaptan. The program was the clinical arm of a much broader Yale ADPKD research program that includes internationally recognized basic research scientists. In recognition of the comprehensive care that her program delivered, the Yale nephrology program earned a Center of Excellence designation and a Patient Navigator Award from the Polycystic Kidney Disease Foundation.
Her skill at translating basic science research findings into clinical practice has led to her being in demand as a speaker in clinical genetics and cystic kidney disease, both nationally at ASN and the National Kidney Foundation and locally to teach about new developments in these evolving areas.
Dr. Dahl has published 65 original articles. She is associate editor for Kidney360 and served on the editorial board of ASN's Kidney Self-Assessment Program. She is a member of the Scientific Advisory Committee of the Polycystic Kidney Disease Foundation, for which she cochaired the Center of Excellence Advisory Board.
She received an MD and a PhD in physiology from Tufts University School of Medicine and then completed a residency and fellowship at the Beth Israel Deaconess Medical Center in Boston, MA.
Ladan Golestaneh, MD, MS, FASN
Dr. Golestaneh is professor of medicine in the Division of Nephrology at the Montefiore Medical Center of the Albert Einstein College of Medicine in New York City. She is also medical director of the Williamsbridge Home Dialysis Center and director of end stage kidney disease at the Montefiore Care Management Organization.
Early in her career, Dr. Golestaneh established Montefiore's first continuous replacement therapy program. From 2006 to 2009, she directed the inpatient hemodialysis facility at Montefiore. In 2009, she became medical director of the Bedford Park Dialysis Center. During this time, she developed the intensive care unit nephrology curriculum at Montefiore and became a consultant to the heart transplant program. In 2012, she joined the Montefiore Care Management Organization as the expert consultant for its population with chronic kidney disease and led multiple innovative projects. In 2014, she became medical director of the Williamsbridge Home Dialysis Center of Excellence.
The next year, Dr. Golestaneh enrolled in the clinical research training program at the Albert Einstein College of Medicine and received her master's degree in clinical research methods. Since completing this degree, she has focused her attention on grant-funded research designed to improve outcomes for patients with kidney diseases.
She is globally recognized through multiple speaking engagements, through numerous publications, as an ad hoc reviewer for major scientific journals, as a content expert and leader for the Centers for Medicare & Medicaid Services’ Kidney Care program, and through multiple research collaborations.
Dr. Golestaneh received her MD from New York Medical College, after which she completed a residency and fellowship in nephrology at the Albert Einstein College of Medicine and Montefiore Medical Center.